glibornuride

was MH 1975-92 (see under SULFONYLUREA COMPOUNDS 1975-90); use SULFONYLUREA COMPOUNDS to search GLIBORNURIDE 1975-92; an oral, sulfonylurea hypoglycemic agent which stimulates insulin secretion

Also Known As:

Networked: 18 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Orak, Haci: 1 article (03/2006)
2.	Ozgey, Yasemin: 1 article (03/2006)
3.	Ozsoy-Sacan, Ozlem: 1 article (03/2006)
4.	Tunali, Tugba: 1 article (03/2006)
5.	Yanardag, Refiye: 1 article (03/2006)
6.	Yarat, Aysen: 1 article (03/2006)

Related Diseases

1.	Type 2 Diabetes Mellitus (MODY) 01/01/1975 - "The multiple-dose pharmacokinetics of 1-(2-endo-hydroxy-3-endo-bornyl)-3-(p-tolyl-sulfonyl)-urea (glibornuride, Glutril¿) was examined in 7 subjects with maturity-onset diabetes treated with the drug over a period of 4 weeks (25 mg every twelve hours). " 05/01/1974 - "A clinical trial of glibornuride in maturity-onset diabetes mellitus." 03/01/1998 - "The effect of glibornuride on the plasma ANF levels and natriuresis was estimated in 10 newly diagnosed NIDDM patients and 10 control subjects. " 03/01/1998 - "The Effect of Glibornuride on Plasma Atrial Natriuretic Factor Levels in Patients with Newly Diagnosed NIDDM." 09/01/1976 - "Clinical comparison between glibornuride (Glutril) and tolbutamide in maturity-onset diabetes: a controlled double-blind trial."
2.	Diabetes Mellitus 04/01/1973 - "Long term treatment of diabetes mellitus with glibornuride. " 11/10/1972 - "[Comparative study with tolbutamide and glibornuride for the diagnosis of latent diabetes mellitus]." 09/01/1975 - "The authors present the results of treatment of the patients with diabetes mellitus with hypoglycaemic preparations (sulphonylurea preparations of the second generation): glibenclamide, glibornuride and glydiazinamide. "
3.	Hypoglycemia (Reactive Hypoglycemia) 01/01/1992 - "All 98 cases of sulfonylurea-induced hypoglycemia reported by the 30 regional drug-monitoring centers between 1985 and 1990 were analyzed: 46 with gliclazide, 40 with glibenclamide, 5 with glipizide, 1 with glibornuride and 6 with first-generation sulfonylureas. " 02/01/1986 - "The risk of hypoglycemia occurring is thus significantly higher under glibenclamide and chlorpropamide than under glibornuride and tolbutamide. "
4.	Flushing 06/01/1994 - "Evident flushing phenomenon was observed in 6 patients treated with chlorpropamide, in 3 treated with tolbutamide, in 2 treated with glibenclamide, in one receiving glibornuride and in none treated with glipizide. " 06/01/1993 - "Evident flushing phenomenon was observed in 6 patients treated with chlorpropamide, in 3 treated with tolbutamide, in 2 treated with glibenclamide, in one receiving glibornuride and in none treated with glipizide. "
5.	Urticaria (Hives) 03/01/1991 - "With special regard to cross reactions between sulfonylurea: we observe the tolerance of glipizide after glibenclamide induced urticaria, tolerance of glicalazide after glibornuride induced Quincke's oedema and eruption, tolerance of glibornuride after chlorporpamide induced urticaria and Quincke's oedema. " 03/01/1991 - "We describe 5 observations of cutaneous reactions or immediate hypersensitivity with different hypoglycemic sulfonylurea: Quincke's oedema with glibornuride, three urticaria (one was followed by bronchospasm and collapsus) with glibenclamide, one bullous dermatitis with carbutamide. "

Related Drugs and Biologics

1.	glibornuride
2.	Glyburide (Glibenclamide)
3.	Tolbutamide (Orinase)
4.	Glipizide (Glucotrol)
5.	Insulin (Novolin)
6.	Chlorpropamide
7.	Solutions
8.	Blood Glucose (Blood Sugar)
9.	N-Acetylneuraminic Acid (Sialic Acid)
10.	Uric Acid (Urate)